ArticleCancer immunology, immunotherapy : CII2026
Downregulation of ANKRD22 promotes ovarian cancer cell proliferation by enhancing the immunosuppressive capacity of M-MDSCs.
Huanhuan Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.